Literature DB >> 19541934

Complement factor h is critical in the maintenance of retinal perfusion.

Peter Lundh von Leithner1, Jaimie Hoh Kam, James Bainbridge, Ian Catchpole, Gerald Gough, Peter Coffey, Glen Jeffery.   

Abstract

Vascular pathologies are known to be associated with age-related macular degeneration. Recently, age-related macular degeneration was associated with a single-nucleotide substitution of the complement factor H (CFH) gene, part of the alternative pathway of the complement system, a critical element in the innate immune response. Such polymorphisms are found in more than 50% of cases of age-related macular degeneration. Here we show that the absence of CFH causes an autoimmune response that targets the vascular endothelium of both the inner and outer retinal vascular networks. In CFH-knockout (cfh(-/-)) mice, C3 and C3b, key components of the complement system, are progressively deposited on retinal vessels, which subsequently become restricted and wither, resulting in a reduction of retinal blood supply. This result leads to increased oxygen stress. While such effects are not systemic, these structural changes are mirrored in functional changes with a substantial decline in retinal blood flow dynamics. When the system is challenged functionally by laser-induced choroidal neovascularization, fluorescein leakage was significantly smaller in cfh(-/-) mice compared with controls, likely due to reduced retinal perfusion. These data reveal that in both the presence and absence of exogenous challenge to the innate immune system, CFH is required to maintain normal levels of retinal perfusion. It is likely that C3 and C3b accumulation in the aged CFH-deficient retina is associated with complement-mediated retinal endothelium destruction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19541934      PMCID: PMC2708826          DOI: 10.2353/ajpath.2009.080927

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

1.  Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium.

Authors:  C Schwesinger; C Yee; R M Rohan; A M Joussen; A Fernandez; T N Meyer; V Poulaki; J J Ma; T M Redmond; S Liu; A P Adamis; R J D'Amato
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

2.  Endothelial cell hypertrophy induced by vascular endothelial growth factor in the retina: new insights into the pathogenesis of capillary nonperfusion.

Authors:  P Hofman; B C van Blijswijk; P J Gaillard; G F Vrensen; R O Schlingemann
Journal:  Arch Ophthalmol       Date:  2001-06

3.  bFGF and VEGF synergistically enhance endothelial cytoprotection via decay-accelerating factor induction.

Authors:  Justin C Mason; Elaine A Lidington; Saifur R Ahmad; Dorian O Haskard
Journal:  Am J Physiol Cell Physiol       Date:  2002-03       Impact factor: 4.249

4.  Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid.

Authors:  P T Johnson; K E Betts; M J Radeke; G S Hageman; D H Anderson; L V Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-01       Impact factor: 11.205

5.  Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction.

Authors:  Peter J Coffey; Carlos Gias; Caroline J McDermott; Peter Lundh; Matthew C Pickering; Charanjit Sethi; Alan Bird; Fred W Fitzke; Annelie Maass; Li Li Chen; Graham E Holder; Philip J Luthert; Thomas E Salt; Stephen E Moss; John Greenwood
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-05       Impact factor: 11.205

6.  Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H.

Authors:  Matthew C Pickering; H Terence Cook; Joanna Warren; Anne E Bygrave; Jill Moss; Mark J Walport; Marina Botto
Journal:  Nat Genet       Date:  2002-07-01       Impact factor: 38.330

7.  AAV-mediated expression of vascular endothelial growth factor induces choroidal neovascularization in rat.

Authors:  Fei Wang; Katherine G Rendahl; William C Manning; Dulce Quiroz; Mazie Coyne; Sheldon S Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-02       Impact factor: 4.799

8.  Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking.

Authors:  Anne E Hughes; Nick Orr; Chris Patterson; Hossein Esfandiary; Ruth Hogg; Vivienne McConnell; Giuliana Silvestri; Usha Chakravarthy
Journal:  PLoS Med       Date:  2007-12       Impact factor: 11.069

9.  Complement factor h gene abnormalities in haemolytic uraemic syndrome: from point mutations to hybrid gene.

Authors:  Marina Noris; Giuseppe Remuzzi
Journal:  PLoS Med       Date:  2006-10       Impact factor: 11.069

10.  Haplotypes in the complement factor H (CFH) gene: associations with drusen and advanced age-related macular degeneration.

Authors:  Peter J Francis; Dennis W Schultz; Sara Hamon; Jurg Ott; Richard G Weleber; Michael L Klein
Journal:  PLoS One       Date:  2007-11-28       Impact factor: 3.240

View more
  24 in total

1.  A chimeric Cfh transgene leads to increased retinal oxidative stress, inflammation, and accumulation of activated subretinal microglia in mice.

Authors:  Bogale Aredo; Tao Li; Xiao Chen; Kaiyan Zhang; Cynthia Xin-Zhao Wang; Darlene Gou; Biren Zhao; Yuguang He; Rafael L Ufret-Vincenty
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

2.  Role of ocular complement factor H in a murine model of choroidal neovascularization.

Authors:  Valeriy V Lyzogubov; Ruslana G Tytarenko; Purushottam Jha; Juan Liu; Nalini S Bora; Puran S Bora
Journal:  Am J Pathol       Date:  2010-09-02       Impact factor: 4.307

Review 3.  Complement factor H in AMD: Bridging genetic associations and pathobiology.

Authors:  Christopher B Toomey; Lincoln V Johnson; Catherine Bowes Rickman
Journal:  Prog Retin Eye Res       Date:  2017-09-18       Impact factor: 21.198

4.  Smoke exposure causes endoplasmic reticulum stress and lipid accumulation in retinal pigment epithelium through oxidative stress and complement activation.

Authors:  Kannan Kunchithapautham; Carl Atkinson; Bärbel Rohrer
Journal:  J Biol Chem       Date:  2014-04-07       Impact factor: 5.157

Review 5.  Complement Activation and Inhibition in Retinal Diseases.

Authors:  Mark E Kleinman; Jayakrishna Ambati
Journal:  Dev Ophthalmol       Date:  2015-10-26

6.  Cfh genotype interacts with dietary glycemic index to modulate age-related macular degeneration-like features in mice.

Authors:  Sheldon Rowan; Karen Weikel; Min-Lee Chang; Barbara A Nagel; Jeffrey S Thinschmidt; Amanda Carey; Maria B Grant; Steven J Fliesler; Donald Smith; Allen Taylor
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-01-23       Impact factor: 4.799

7.  Systemic administration of Abeta mAb reduces retinal deposition of Abeta and activated complement C3 in age-related macular degeneration mouse model.

Authors:  Ian Catchpole; Volker Germaschewski; Jaimie Hoh Kam; Peter Lundh von Leithner; Susannah Ford; Gerald Gough; Peter Adamson; Philip Overend; Jan Hilpert; Francisco J López; Yin Shan Eric Ng; Pete Coffey; Glen Jeffery
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

Review 8.  Complement System and Potential Therapeutics in Age-Related Macular Degeneration.

Authors:  Young Gun Park; Yong Soo Park; In-Beom Kim
Journal:  Int J Mol Sci       Date:  2021-06-25       Impact factor: 5.923

9.  Treatment with 670 nm light up regulates cytochrome C oxidase expression and reduces inflammation in an age-related macular degeneration model.

Authors:  Rana Begum; Michael B Powner; Natalie Hudson; Chris Hogg; Glen Jeffery
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

10.  Alterations of choroidal blood flow regulation in young healthy subjects with complement factor H polymorphism.

Authors:  Reinhard Told; Stefan Palkovits; Helmuth Haslacher; Sophie Frantal; Doreen Schmidl; Agnes Boltz; Michael Lasta; Semira Kaya; René M Werkmeister; Gerhard Garhöfer; Leopold Schmetterer
Journal:  PLoS One       Date:  2013-04-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.